Sam H Ahmedzai Academic Unit of Supportive Care Department of Oncology The University of Sheffield & Sheffield Teaching Hospitals NHS Foundation
|
|
- Mark Ford
- 5 years ago
- Views:
Transcription
1 Sam H Ahmedzai Academic Unit of Supportive Care Department of Oncology The University of Sheffield & Sheffield Teaching Hospitals NHS Foundation Trust
2 Overview Which drugs? How much? How to give? Adverse effects (Oxygen and airflow will not be covered)
3 Don t forget value of anti-cancer treatments for palliating dyspnoea 1. Radiotherapy Cachia, Ahmedzai Eur J Cancer 2008
4 Don t forget value of anti-cancer treatments for palliating dyspnoea 2. Chemotherapy Cachia, Ahmedzai Eur J Cancer 2008
5 Supp Care Cancer 2008 Opioids Benzodiazepines Phenothazines
6 Actions of drugs on dyspnoea Cachia, Ahmedzai Eur J Cancer 2008 Drug class Pharmacological action Opioid Benzodiazepine Relieves dyspnoea at cerebral level? Reduces ventilatory response to hypercapnia Reduces anxiety Causes sedation Relieves pain? Reduces cough Reduces cardiac pre-load Reduces cardiac after-load Reduces afferent signalling from lungs?
7 Opioids for palliation of dyspnoea Where do opioids act to reduce sensation? Depression of medullary chemoreceptors may not be relevant (Muers, 2002) PET and fmri evidence of dyspnoea activation of anterior cingulate gyrus, insula, amygdala similar areas for pain, thirst, hunger (Liotti et al, 2000) Possibility that opioid receptors in these areas can modulate sensation and affective response to dyspnea - without involving respiratory drive
8 Benefits of opioids in dyspnea Relief of dyspnoea Improved exercise tolerance Relief of cough Relief of chest pain Sedation / reduction in anxiety Cardiovascular relief in left ventricular failure
9 Actions of opioids in dyspnoea Drug Codeine Dihydrocodeine What does it do? No benefit Effective - but weak and side-effects Morphine COPD Cancer Exercise tolerance Conflicting evidence on dyspnoea Effective
10 11 patients admitted to palliative care unit Non-randomised, uncontrolled study Detailed comparison of effects of nasal oxygen with morphine Series of studies by this group and others Show that opioids rapidly reduce ventilation (respiratory rate) But tidal volume can go up so minute ventilation (SaO 2 ) remains steady (at first)
11 Significant reduction of dyspnoea after morphine but not oxygen
12 Respiratory rate decreased significantly with morphine but no other evidence of respiratory depression
13 Significant reduction of ANXIETY with morphine was this the main effect?
14 BMJ 2003 Double blind RCT Slow release morphine 20mg daily versus placebo + Docusate + Senna Improvement in dyspnoea scores (but clinically significant?) Major problem with constipation
15 BMJ 2003
16
17 Which opioid to use for dyspnoea? No head to head comparisons! Reasons to avoid morphine Higher rates of constipation, nausea, sedation cf fentanyl (Ahmedzai 1997; Clark 2004) Higher rate of cognitive effects cf oxycodone (Mucci-LoRusso 1998) Morphine releases histamine and tryptase via mast cell degranulation not by fentanyl or buprenorphine (non-opioid effect Blunk 2004) Buprenorphine has least respiratory depressant effect of all current opioids
18 JPSM 2013
19 What about buprenorphine? Complex activity at opioid receptors Partial agonist at mu Antagonist at kappa Agonist at ORL-1 Largely ignored by palliative medicine because of lack of understanding of actions emetic side-effects with immediate release oral preparation New sustained release patch
20
21
22
23 Benzodiazepines for dyspnoea Evidence for relief of anxiety and possibly dyspnoea in COPD Risk of sedation or benefit? Buspirone less respiratory depression, but slow onset Lorazepam better than diazepam - shorter half-life and cleaner metabolism Midazolam for rapid titration + syringe drive
24 Navigante et al, JPSM 2006
25 Navigante et al, JPSM 2006
26 Navigante et al, JPSM 2006
27 Navigante et al, JPSM 2006
28 JPSM 2012
29 What s new? Nebulised furosemide (20-40mg) Acts on airways mechanical receptors Modulates afferent neural pathways Reduces bronchospasm Variable results in dyspnoea Positive small uncontrolled series (Nishino et al, 2000) Positive study in volunters (Moosavi et al, 2006) Negative studies in palliative care (Stone, 2002; Wilcock 2008)
30 10 volunteers Enforced air hunger by restricted ventilation and induced hypercapnia Dyspnoea measured on 100mm VAS Nebulised 40mg furosemide vs placebo Air hunger reduced from 58 to 39 Allowing for placebo, effect was 13% of full scale (p=0.052) Subjects had diuresis
31
32 No changes in respiratory parameters (PCO 2 or VE)
33
34
35
36 Actions of drugs on dyspnoea Cachia, Ahmedzai Eur J Cancer 2008 Drug class Pharmacological action Relieves dyspnoea at cerebral level Reduces ventilatory response to hypercapnia Opioid Benzodiazepine Nebulised furosemide? Reduces anxiety Causes sedation Relieves pain? Reduces cough Reduces cardiac pre-load Reduces cardiac after-load? Reduces afferent signalling from lungs?
37
38 What are the challenges?
39 JPSM 2012
40 J Pall Med 2012
41 J Pall Med 2012
42 J Pall Med 2012
43 J Pall Med 2012
44 What are the challenges? Which drugs especially opioids Which route How to titrate? Combinations of drugs Breakthrough dyspnea
45
Dyspnea: Evaluation and Management
Dyspnea: Evaluation and Management Sandra Whitlock, M.D. Four Seasons Palliative Care Course Handouts & Post Test o To download presentation handouts, click on the attachment icon o Presenter discloses
More informationDyspnea. Stephanie Lindsay
Dyspnea Stephanie Lindsay What is dyspnea? An unpleasant sensation of difficult, labored breathing Shortness of air Dyspnea is not the same as tachypnea therefore patients may not present with rapid breathing
More informationPalliative care for heart failure patients. Susan Addie
Palliative care for heart failure patients Susan Addie Treatments The most common limiting and distressing complaint is of fatigue and breathlessness. Optimal treatment strategies relieve symptoms, improves
More informationJeffrey B. Rubins, MD Director, Palliative Medicine, HCMC Professor of Medicine, UMN
Jeffrey B. Rubins, MD Director, Palliative Medicine, HCMC Professor of Medicine, UMN Mechanisms of dyspnea otreat reversible causes opalliation of refractory dyspnea Dyspnea Analogous to pain Dyspnea is
More informationBreathlessness in advanced disease. February 2017
Breathlessness in advanced disease February 2017 Breathlessness Managing breathlessness in primary care Chronic breathlessness Acute exacerbation of breathlessness Breathlessness at end of life Breathlessness
More informationJamie Rickards, PharmD, MBA, BCPS, CPP PGY-2 Geriatric Pharmacy Resident
Jamie Rickards, PharmD, MBA, BCPS, CPP PGY-2 Geriatric Pharmacy Resident jrickard@unch.unc.edu Background 1,2 Dyspnea- derives from Greek dys - abnormal/difficult and pnoia meaning breath Defined as uncomfortable
More informationManaging Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.
Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital. Things to consider: 1. Very common symptoms. 2. Can occur in any
More informationPalliative care Non-malignant Respiratory Disease. Scott Davidson Queen Elizabeth University Hospital Glasgow
Palliative care Non-malignant Respiratory Disease Scott Davidson Queen Elizabeth University Hospital Glasgow UK deaths Place All deaths (%) Malignant (%) Hospital 66.5 55.5 Hospice 4.3 16.5 Other communal
More informationPAIN MANAGEMENT Patient established on oral morphine or opioid naive.
PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationWR Fentanyl Symposium. Opioids, Overdose, and Fentanyls
Opioids, Overdose, and Fentanyls Outline: What are opioids? Why are we experiencing and opioid crisis? Potency, purity, and product How do opioids cause overdose and overdose deaths? What is naloxone and
More informationApproach to symptom control near the end-of-life
Approach to symptom control near the end-of-life 18 Sept 2011 Dr Alethea Yee Senior Consultant, Department of Palliative Medicine National Cancer Centre,Singapore What is end of life? No precise definition
More informationAgonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone
Opioid Definition All drugs, natural or synthetic, that bind to opiate receptors Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid agonists increase pain threshold
More informationBREATHLESSNESS MANAGEMENT
Guideline Name: Breathlessness BACKGROUND Breathlessness is a common symptom in patients with cancer, end-stage heart failure and end-stage chronic obstructive pulmonary disease (COPD). There are many
More informationPRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT
PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,
More informationPalliative Emergencies. Ken Stakiw
Palliative Emergencies Ken Stakiw Disclosure None to disclose for this lecture Have received honoraria from a number of agencies and companies previously Intend to discuss some off label use of medications
More informationSupportive Care. End of Life Phase
Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of
More informationMMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life
MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be
More informationBe courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.
1 2 EMT OPTIONAL SKILL Naloxone Intranasal Cell Phones and Pagers Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. 3 4 5 6 Course Outline Introduction
More informationCare of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.
Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients
More informationManagement of Dyspnea and Cough in Lung Cancer
Management of Dyspnea and Cough in Lung Cancer Dr. Chris Ogaranko Lung Cancer Educational Event November 2013 Presenter Disclosure Faculty: Dr. Chris Ogaranko Relationships with commercial interests: Grants/Research
More informationNaloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017
EMT OPTIONAL SKILL Naloxone Intranasal Cell Phones and Pagers Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. Course Outline Introduction and Overview
More informationPeripheral mechanisms of dyspnoea
Peripheral mechanisms of dyspnoea Miriam Johnson 2012 A complex interaction respiratory motor areas of the brain receive information and commands required ventilation ascending copy of descending motor
More informationDyspnea: The top things you need to you know! Dr. Megan Sellick & Dr. Lawrence Lee Edmonton Zone Palliative Care Program
: The top things you need to you know! Dr. Megan Sellick & Dr. Lawrence Lee Edmonton Zone Palliative Care Program Faculty / Presenter Disclosure Faculty: Dr. Lawrence Lee Relationships with commercial
More informationFor patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.
Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative
More informationRegional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.
Regional Breathlessness Audit - Case te Survey 1. Introduction Please complete this form for your case note review. Cases used may be PROSPECTIVE AND/OR RETROSPECTIVE. Please log as many cases as you can.
More informationSymptom Management Guidelines for End of Life Care
Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can
More informationPAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE
PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A
More informationHospice and Palliative Nurses Association (HPNA) Clinical Practice Forum October 23 24, 2015
Dyspnea Assessment and Treatment at the End of Life Margaret L. Campbell, PhD, RN, FPCN Professor, Wayne State University Detroit, MI Disclosures Margaret Campbell has no real or perceived conflicts of
More informationConservative Management of Uraemia
Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist
More informationSYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL
SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation
More informationPAIN MANAGEMENT Person established taking oral morphine or opioid naive.
PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationRenal Palliative Care Last Days of Life
Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr
More informationTitle: Pharmacological Management for Dyspnea in Palliative Cancer Patients: Clinical Review and Guidelines
Title: Pharmacological Management for Dyspnea in Palliative Cancer Patients: Clinical Review and Guidelines Date: 10 July 2008 Context and policy issues: Dyspnea, defined as a subjective experience of
More informationBreathlessness: what we know, and what we don t know
Breathlessness: what we know, and what we don t know Miriam Johnson Dansk Selskab for Palliativ Medicin 2014 ST CATHERINE S HOSPICE Overview epidemiology impact and assessment management ST CATHERINE S
More informationTezko dihanje - Dyspnea in patients with advanced disease
Tezko dihanje - Dyspnea in patients with advanced disease Ljubjana, 20.102017 Gudrun Kreye Division for Palliative Care, 2. Medizinische Abteilung, University Hospital Krems No conflict of interest to
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
More informationDoncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary
Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017
More informationNarcotic Analgesics. Jacqueline Morgan March 22, 2017
Narcotic Analgesics Jacqueline Morgan March 22, 2017 Pain Unpleasant sensory and emotional experience with actual or potential tissue damage Universal, complex, subjective experience Number one reason
More informationPain Management Strategies Webinar/Teleconference
Pain Management Strategies Webinar/Teleconference Barry K. Baines, MD April 16, 2009 Objectives Describe the principles of pain management. Identify considerations in the use of opioids. Describe the benefits
More information10/08/59 PAIN IS THE MOST COMMON TREATABLE SYMPTOM OF CANCER CURRENT EVIDENCE BASED CONCEPTS: MANAGEMENT OF CANCER PAIN PAIN AN UNMET CLINICAL NEED IN
Pain is a frequent complication of cancer, and is common in many other life-limiting illnesses MANAGEMENT OF CANCER PAIN A/Prof Ghauri Aggarwal FRACP, FAChPM, FFPMANZCA Palliative Medicine Physician Sydney
More informationInterprofessional Webinar Series
Interprofessional Webinar Series Opioids in the Medically Ill: Principles of Administration Russell K. Portenoy, MD Chief Medical Officer MJHS Hospice and Palliative Care Director MJHS Institute for Innovation
More informationObjectives. Ethical Issues at EOL: Deciding When to Use Oxygen and Antibiotics. Dyspnea. To Palliate 4/28/2014
Objectives Ethical Issues at EOL: Deciding When to Use Oxygen and Antibiotics Marcia Levetown, MD, FAAHPM HealthCare Communication Associates mlevetown@earthlink.net Understand the evidence based use of
More informationWhat is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?
What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls? What is an opioid? What do opioids do?: The term opioid can be
More informationPALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST
PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted
More informationCare of the Dying Management in Severe Renal Failure
Care of the Dying Management in Severe Renal Failure Clinical Guideline Early recognition of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance
More informationCare of the Dying Management in Severe Renal Failure
Care of the Dying Management in Severe Renal Failure Clinical Guideline Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance
More informationRenal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life
Guidance for Anticipatory prescribing for patients in renal failure (egfr
More informationNew Medicines Committee Briefing November 2011 Abstral (sublingual fentanyl citrate tablet) for the management of breakthrough cancer pain
New Medicines Committee Briefing November 2011 Abstral (sublingual fentanyl citrate tablet) for the management of breakthrough cancer pain Abstral is to be reviewed for use within: Primary Care Secondary
More informationOxygen Use in Palliative Care Guideline and Flowchart
Oxygen Use in Palliative Care Guideline and Flowchart Reviewed: October 2013 Gippsland Region Palliative Care Consortium Clinical Practice Group Policy. Title Keywords Ratified Oxygen Use in Palliative
More informationRegional Renal Training
Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing
More informationSupporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety
Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of
More informationSymptom Control in Heart Failure. Dr Claire L Hookey
Symptom Control in Heart Failure Dr Claire L Hookey Heart Failure symptoms Class III/IV CHF, mean 67.1 years, mean EF 22.3% Most prevalent symptoms:- lack of energy (66%) dry mouth (62%) shortness of breath
More informationObjectives: What is your Definition of Pain? 8/16/2017
Safe Opioid Management for the Seriously Ill Patient Sam Perna, D.O. Objectives: MDB1 1) Participants will understand the way the body s pain system works. 2) Participants will identify the elements of
More informationSymptom Control in the Community Setting. Dr Andrew Tysoe-Calnon
Symptom Control in the Community Setting Dr Andrew Tysoe-Calnon Lead Consultant t Common symptoms Pain Agitation Shortness of breath Nausea and vomiting Intestinal obstruction Confusion Pain Occurs in
More informationPOST-INTUBATION ANALGESIA AND SEDATION. August 2012 J Pelletier
POST-INTUBATION ANALGESIA AND SEDATION August 2012 J Pelletier Intubated patients experience pain and anxiety Mechanical ventilation, endotracheal tube Blood draws, positioning, suctioning Surgical procedures,
More information1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER
1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1.1 GENERAL PRINCIPLES There are many causes of agitation in palliative care patients, which makes recommendations for treatment difficult.
More informationThe Role of Palliative Care in Advanced Lung Disease
The Role of Palliative Care in Advanced Lung Disease Timothy B. Short, MD, FAAFP, FAAHPM Associate Professor, Palliative Medicine University of Virginia Learning Objectives Describe palliative care s approach
More informationANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT
ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL Doses of opiates must be proptional to current analgesic medication Please refer ALL patients on Methadone Ketamine to SPCT f advice. Patients
More informationFacts About Morphine and Other Opioid Medicines In Palliative Care. Find out more at: palliativecare.my. Prepared by: Printing sponsored by:
Facts About Morphine and Other Opioid Medicines In Palliative Care Find out more at: palliativecare.my Prepared by: Printing sponsored by: What is this brochure about? Opioid medicines are pain relievers.
More informationAttitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians
Original Article Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians Chronic Respiratory Disease 2015, Vol. 12(2) 85 92 ª The Author(s) 2015 Reprints and permission: sagepub.co.uk/journalspermissions.nav
More informationBenzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults (Review)
Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults (Review) Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C This is a reprint of a Cochrane
More informationOpioid Type Pain Killers
Opioid Type Pain Killers Information for patients, relatives and carers For more information, please contact: Palliative Care Team 01904 725835 (York) 01723 342446 (Scarborough) Renal Department 01904
More informationMid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care
Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage
More informationPRACTICAL DYSPNEA MANAGEMENT Margot Sondermann BScPT, MEd. Palliative Consultant for End-Stage Lung Disease, Calgary Zone
PRACTICAL DYSPNEA MANAGEMENT Margot Sondermann BScPT, MEd. Palliative Consultant for End-Stage Lung Disease, Calgary Zone Faculty / Presenter Disclosure Faculty: Margot Sondermann Relationships with commercial
More informationUsing Evidence Based Medicine to Ethically Provide End of Life Symptom Control
Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control Erin Zimny, MD Emergency Medicine Hospice and Palliative Medicine Henry Ford Hospital Disclosures I do NOT have any financial
More informationDyspnea. Latest Research in Management of Breathlessness and Current Use of Diagnostic Tools Elissa Tiller, MD Karin Lee Hughes, MD
Foundations in Palliative Medicine Palliative Care Interdisciplinary Curriculum Colorado, November 2017 Dyspnea Latest Research in Management of Breathlessness and Current Use of Diagnostic Tools Elissa
More informationFarmaci inalatori e dispnea nell asma e nella BPCO. Federico Lavorini
Farmaci inalatori e dispnea nell asma e nella BPCO Federico Lavorini Dept. Experimental and Clinical Medicine Careggi University Hospital Florence - Italy Presenter Disclosures F.L. has received in the
More informationUSE OF BUPRENORPHINE FOR CHRONIC PAIN
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences USE OF BUPRENORPHINE FOR CHRONIC PAIN MARK SULLIVAN, MD, PHD PSYCHIATRY AND BEHAVIORAL SCIENCES ANESTHESIOLOGY AND
More informationGG&C Chronic Non Malignant Pain Opioid Prescribing Guideline
GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline Background Persistent pain is common, affecting around five million people in the UK. For many sufferers, pain can be frustrating and disabling,
More informationOpioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms:
Opioid Overdose Best Practices Guideline Table of Contents A. General description B. Typical signs and symptoms C. Expected course D. Making the diagnosis E. Recommended treatment F. Criteria for hospital
More informationFentanyls and Naloxone. Opioids, Overdose, and Naloxone
Opioids, Overdose, and Naloxone Presenter Disclosure Presenter s Name: Michael Beazely I have no current or past relationships with commercial entities Speaking Fees for current program: I have received
More informationCare in the Last Days of Life
Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient
More information4/3/2018. Management of Acute Pain Crises. Five Mistakes I ve made and why you shouldn t
Management of Acute Pain Crises Maggie O Connor, M.D. Retired Palliative Care Physician Hope is not the conviction that something will turn out well, but the certainty that something makes sense, regardless
More informationPediatric Dental Sedation
Pediatric Dental Sedation L. Stephen Long, MD Pediatric Anesthesiologist Children s Dental Anesthesia Group UCSF Benioff Children s Hospital Oakland Part 1: Pediatric Airways and Lungs 1 Three questions:
More informationPalliative care in long-term conditions Scottish Palliative Care Pharmacists Association
Palliative care in long-term conditions 2011 2012 Scottish Palliative Care Pharmacists Association Aims & Objectives To explore symptoms, general management principles and appropriate palliative treatment
More informationAPHN. Shortness of breath. Ednin Hamzah CEO, Hospis Malaysia.
APHN Shortness of breath Ednin Hamzah CEO, Hospis Malaysia ednin@hospismalaysia.org What is it? a subjective experience of difficult and uncomfortable breathing American Thoracic Society What do the patients
More informationSlide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists
Slide 1 Opioid (Narcotic) Analgesics and Antagonists Chapter 6 1 Slide 2 Lesson 6.1 Opioid (Narcotic) Analgesics and Antagonists 1. Explain the classification, mechanism of action, and pharmacokinetics
More informationPain management. Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD
Pain management Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD Case #1 61 yo man with history of Stage 3 colon cancer, s/p resection and adjuvant chemotherapy with FOLFOX
More informationPAIN. Physiology of pain relating to pain management
PAIN Physiology of pain relating to pain management What is pain? An unpleasant sensory and emotional experience associated with actual or potential tissue damage. (Melzac and Wall) The generation of pain
More information6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages
Nalbuphine: Analgesic with a Niche Mellar P Davis MD FCCP FAAHPM 1 Summary of Advantages Safe in renal failure- fecal excretion Analgesia equal to morphine with fewer side effects Reduced constipation
More informationPalliative Care Emergencies. Additional module if needed
Palliative Care Emergencies Additional module if needed Learning objectives Understand emergency /urgent / important Describe common emergencies in PC Explore principles of essential management Outline
More informationOP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4
Opioid MCQ OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4 OP02 [Mar96] Which factor does NOT predispose to bradycardia with
More informationControlled Document Number: Version Number: 1. Controlled Document Sponsor: Controlled Document Lead (Author): On: July Review Date: July 2020
Guidelines for the Use of Naloxone in Palliative Care in Adult Patients CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: Controlled Document Number: Version Number: 1 Controlled Document Sponsor: Controlled
More informationTREATING RESPIRATORY SYMPTOMS IN PEDIATRIC PALLIATIVE CARE: Objectives 10/23/18 FROM DYSPNEA TO NOISY BREATHING
TREATING RESPIRATORY SYMPTOMS IN PEDIATRIC PALLIATIVE CARE: FROM DYSPNEA TO NOISY BREATHING Kris Catrine, MD, FAAP, HMDC October 24, 2018 Objectives Discuss pathophysiology of common respiratory symptoms
More informationOPIOIDS AND NON-CANCER PAIN
Ch05.qxd 1/6/04 4:33 PM Page 77 CHAPTER 5 OPIOIDS AND NON-CANCER PAIN Background 78 Side-effects of opioids 78 Tolerance, physical dependence and addiction 79 Opioid-induced pain 79 Practical issues 80
More informationDr. A. Kerigan BREATHLESSNESS AT THE END OF LIFE
Dr. A. Kerigan BREATHLESSNESS AT THE END OF LIFE Faculty/Presenter Disclosure Faculty: Dr. A. Kerigan Relationships with commercial interests:* - Grants/Research Support: None - Speakers Bureau/Honoraria:
More informationPain Module. Opioid-RelatedRespiratory Depression (ORRD)
Pain Module Opioid-RelatedRespiratory Depression (ORRD) Characteristics of patients who are at higher risk for Opioid- Related Respiratory Depression (ORRD) Sleep apnea or sleep disorder diagnosis : typically
More informationAnalgesics: Management of Pain In the Elderly Handout Package
Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed
More informationPAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)
Pain - subjective experience associated with detection of tissue damage ( nociception ) acute - serves as a warning chronic - nociception gone bad often accompanied by clinical depression fibromyalgia,
More informationManagement of Dyspnea/Breathlessness for the Medical and Hematological Oncologist
Management of Dyspnea/Breathlessness for the Medical and Hematological Oncologist Author: Jeff Myers MD, CCFP, MSEd Program Head Integrated Psychosocial, Supportive, Palliative Care Program Odette Cancer
More informationAdvances in Palliative Care
Steven Pantilat, MD Professor of Clinical Medicine Alan M. Kates and John M. Burnard Endowed Chair in Palliative Care Director, Palliative Care Program and Palliative Care Leadership Center Division of
More informationGestione della dispnea nell insufficienza respiratoria end-stage
Gestione della dispnea nell insufficienza respiratoria end-stage Salvatore M. Maggiore, MD, PhD salvatore.maggiore@unich.it Anesthesia and Intensive Care SS. Annunziata Hospital Gabriele d Annunzio University
More informationSAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Naloxone for Opiate Overdose
SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY Administration of Naloxone for Opiate Overdose Disclaimer: Authorization - EMT Optional Skills Only authorized Emergency Medical Technicians (EMT) who
More informationEnd of life prescribing guidance
End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly
More informationChronic Obstructive Pulmonary Disease (COPD) Measures Document
Chronic Obstructive Pulmonary Disease (COPD) Measures Document COPD Version: 3 - covering patients discharged between 01/10/2017 and present. Programme Lead: Jo Higgins Clinical Lead: Dr Paul Albert Number
More informationGUIDELINES AND AUDIT IMPLEMENTATION NETWORK
GUIDELINES AND AUDIT IMPLEMENTATION NETWORK General Palliative Care Guidelines The Management of Pain at the End Of Life November 2010 Aim To provide a user friendly, evidence based guide for the management
More informationOpioid Pharmacology. Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd. Consultant Anaesthetist Sheffield Teaching Hospitals
Opioid Pharmacology Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd Consultant Anaesthetist Sheffield Teaching Hospitals Introduction The available opioids and routes of administration - oral
More informationNebulized Versus Subcutaneous Morphine for Patients with Cancer Dyspnea: A Preliminary Study
Vol. 29 No. 6 June 2005 Journal of Pain and Symptom Management 613 Clinical Note Nebulized Versus Subcutaneous Morphine for Patients with Cancer Dyspnea: A Preliminary Study Eduardo Bruera, MD, Raul Sala,
More informationNOVIDADES NO TRATAMENTO COM OPIOIDES. Novelties in therapeutic with opioids. V Congresso National de Cuidados Palliativos Marco 2010, Lisboa
NOVIDADES NO TRATAMENTO COM OPIOIDES Novelties in therapeutic with opioids V Congresso National de Cuidados Palliativos 11 12 Marco 2010, Lisboa Friedemann Nauck Department Palliative Medicine Center Anesthesiology,
More informationEvidence-based practice of palliative care for patients with chronic chest diseases
Evidence-based practice of palliative care for patients with chronic chest diseases Dr KS Lau Consultant (Respiratory Med & Palliative Care) Integrated Medical Services RTSKH Hong Kong Palliative Care
More information